AcelRx Pharmaceuticals (ACRX) PT Lowered to $6 at RBC Capital May 9, 2019 06:41AM
AcelRx Pharma (ACRX) Prices 12.698M Share Common Offering at $3.15/Sh Nov 9, 2018 09:12AM
AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock Nov 9, 2018 09:10AM
AcelRx Pharma (ACRX) Announces Proposed Common Offering Nov 9, 2018 07:07AM
AcelRx Pharmaceuticals Announces Proposed Public Offering of Common Stock Nov 9, 2018 07:00AM


Mar 9, 2018 09:23AM Pre-Open Movers 03/09: (PDLI) (ACRX) (ECYT) Higher; (AUTO) (VNRX) (BIG) Lower (more...)
Feb 16, 2018 07:00AM AcelRx Pharmaceuticals to Present at 2018 RBC Capital Markets Global Healthcare Conference
Mar 3, 2017 06:27AM RBC Capital Reiterates Outperform Rating and $6 PT on AcelRx Pharmaceuticals (ACRX) Following 4Q Results; N-T Focus on DSUVIA
Feb 7, 2017 07:00AM AcelRx Pharmaceuticals to Participate at Four Upcoming Investor Events in February
Aug 16, 2016 08:04AM RBC Capital Remains Bullish on AcelRx Pharma (ACRX) Following Positive SAP302 Trial
Feb 3, 2016 07:00AM AcelRx Pharmaceuticals to Present at Two Upcoming Investor Events in February
Oct 30, 2015 10:37AM Notable Analyst Rating Changes 10/30: (PPL) (ACRX) (ON) Upgraded; (ACGL) (NYCB) (PZZA) Downgraded
Sep 21, 2015 12:00PM Streetinsider.com's Hot Lunchtime Reads 9/21: (MNK) (BBRY) (AMZN) (P)
Sep 21, 2015 11:14AM AcelRx Pharma (ACRX) Strengthens Cash Position for Regulatory with Zalviso Monetization - RBC Capital
Mar 9, 2015 09:27AM Pre-Open Stock Movers 03/09: (RTI) (PNK) (AVEO) Higher; (ACRX) (POZN) (LITB) Lower (more...)
Jan 6, 2014 05:15PM RBC Capital Starts AcelRx Pharmaceuticals (ACRX) at Outperform